Portola Pharmaceuticals Announces Full Results of Phase 3 APEX Study of Betrixaban Presented at International Society on Thrombosis and Haemostasis (ISTH) Meeting
Heliostar Metals to Present at the Precious Metals & Critical Minerals Virtual Investor Conference October 14
